EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Durable Global Correction of CNS and PNS and Lifespan Rescue in Murine Globoid Cell Leukodystrophy via AAV9-Mediated Monotherapy

Dar-Shong Lin, Che-Sheng Ho iD, Yu-Wen Huang iD, Tsung-Han Lee, Zo-Darr Huang, Tuan-Jen Wang, Wern-Cherng Cheng iD, Sung-Fu Huang

Cells · 2025

DOI: 10.3390/cells14241942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Dar-Shong Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, MacKay Memorial Hospital, Taipei 104217, Taiwan. Hauptthemen laut MEDLINE: Leukodystrophy, Globoid Cell, Dependovirus, Central Nervous System, Genetic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council Taiwan, MacKay Memorial Hospital Taiwan, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globoid cell leukodystrophy (GLD) is a devastating lysosomal storage disorder caused by galactocerebrosidase (GALC) deficiency, leading to cytotoxic psychosine accumulation, broad neuroinflammation, dysfunction of autophagy and ubiquitin-proteasome system, progressive demyelination in both the central (CNS) and peripheral nervous systems (PNS), and premature death. Curative treatments are lacking, highlighting the urgent need for transformative approaches. Existing therapies have failed to achieve durable metabolic correction across neural compartments or sustained functional recovery. Here, we demonstrate that a single intracranial administration of high-titer AAV9-GALC targeting the thalamus and deep cerebellar nuclei achieves unprecedented and lifelong therapeutic efficacy in the Twitcher mouse model of GLD. This region-specific monotherapy achieved broad neuronal and glial transduction throughout the CNS and PNS, resulting in sustained supraphysiological GALC activity and complete normalization of psychosine levels. Treated mice exhibited preserved proteostasis, axonal architecture, and myelin integrity, inhibition of neuroinflammation, alongside restored motor function. Remarkably, treated mice attain lifespans approaching wild-type levels, far surpassing all previously reported interventions in this model, indicating a durable, possibly lifelong therapeutic effect. By achieving durable and comprehensive metabolic and structural correction across neural systems without repeated dosing, multi-route delivery, combinational therapy, hematopoietic stem cell transplantation, or high-dose systemic delivery, this study establishes CNS-directed AAV9 monotherapy as a clinically translatable and potentially lifelong therapeutic paradigm for GLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukodystrophy, Globoid CellDependovirusCentral Nervous SystemGenetic TherapyLongevityAnimalsMiceGalactosylceramidaseDisease Models, AnimalPsychosineMice, Inbred C57BLHumansGenetic Vectors

Stichwörter der Autor:innen

AAVGALCautophagydemyelinationgene therapygloboid cell leukodystrophyneuroinflammationpsychosine

Substanzen

GalactosylceramidasePsychosine

Autor:innen und Institutionen

  • Department of Translational Medicine, MacKay Memorial Hospital, Taipei 104217, Taiwan.
  • Department of Medicine, MacKay Medical University, New Taipei 252005, Taiwan.
  • Department of Pediatrics, MacKay Memorial Hospital, Taipei 104217, Taiwan.
  • Department of Neurology, MacKay Children's Hospital, Taipei 104217, Taiwan.
  • Department of Medical Research, MacKay Memorial Hospital, Taipei 104217, Taiwan.
  • Department of Laboratory Medicine, MacKay Memorial Hospital, Taipei 104217, Taiwan.

ORCID-Profile: Che-Sheng Ho, Yu-Wen Huang, Wern-Cherng Cheng

Förderung

  • National Science and Technology Council Taiwan
  • MacKay Memorial Hospital Taiwan
  • National Science and Technology Council
  • MacKay Memorial Hospital

Zitieren

APA

Lin, D. S., Ho, C. S., Huang, Y. W., Lee, T. H., Huang, Z. D., Wang, T. J., Cheng, W. C., & Huang, S. F. (2025). Durable Global Correction of CNS and PNS and Lifespan Rescue in Murine Globoid Cell Leukodystrophy via AAV9-Mediated Monotherapy. Cells. https://doi.org/10.3390/cells14241942

Vancouver

Lin DS, Ho CS, Huang YW, Lee TH, Huang ZD, Wang TJ, et al. Durable Global Correction of CNS and PNS and Lifespan Rescue in Murine Globoid Cell Leukodystrophy via AAV9-Mediated Monotherapy. Cells. 2025. doi:10.3390/cells14241942

BibTeX
@article{Lin2025,
  author = {Lin, Dar-Shong and Ho, Che-Sheng and Huang, Yu-Wen and Lee, Tsung-Han and Huang, Zo-Darr and Wang, Tuan-Jen and Cheng, Wern-Cherng and Huang, Sung-Fu},
  title = {Durable Global Correction of CNS and PNS and Lifespan Rescue in Murine Globoid Cell Leukodystrophy via AAV9-Mediated Monotherapy},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14241942}
}
Kostenlos starten →